IPW
AKRO

Impact Partnership Wealth’s Akero Therapeutics AKRO Stock Holding History

Impact Partnership Wealth’s Portfolio AKRO Stock Details AKRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-28
Closed -$1.31K – 999
2023
Q2 		$1.31K Buy
+28
New +$1.28K ﹤0.01% 752

Other funds holding AKRO

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return

Impact Partnership Wealth's AKRO Position: Q3 2023 in Review

Impact Partnership Wealth sold out of Akero Therapeutics (AKRO) in Q3 2023, closing a stake of 28 shares — an estimated $1.31K sold.

Impact Partnership Wealth first reported a position in AKRO in Q2 2023 and held it in 1 quarter. The position peaked at $1.31K in Q2 2023. 181 funds tracked by Wall St. Rank hold AKRO as of Q3 2023.

  • Impact Partnership Wealth reported no remaining Akero Therapeutics position as of Q3 2023 after selling out during the quarter.
  • Impact Partnership Wealth sold 28 Akero Therapeutics shares in Q3 2023, an estimated $1.31K.
  • Impact Partnership Wealth first reported a position in Akero Therapeutics in Q2 2023 and held it in 1 quarter.
  • Impact Partnership Wealth's Akero Therapeutics position peaked at $1.31K in Q2 2023.
  • 181 funds tracked by Wall St. Rank held Akero Therapeutics as of Q3 2023.

Based on Impact Partnership Wealth's 13F filing for Q3 2023, filed 17 Oct 2023.